Homoeopathic management of Post Covid Syndrome

Assessment of IgG level in Persistent Post Covid Syndrome by administration of Calcarea carbonicum in 200th potency - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060629

Enrollment

Registered

2023-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Control Intervention1: Calcarea carbonicum 200C: Dose 200C Frequency weekly once 1 dose Route of administration Oral route Duration for 6 months Control Intervention2: Placebo: Placebo weekly once one

Eligibility

Inclusion criteria

Inclusion criteria: Symptomatic Covid patients Cases associated with the systemic illness Confirmed cases of RT-PCR

Exclusion criteria

Exclusion criteria: Age below 18 years and above 65 years Asymptomatic Covid patients Patients with acute emergency conditions

Design outcomes

Primary

Measure	Time frame
Assessemnet of improvement by scoring chart of Delphi panel on monthly basisTimepoint: First assessment at 3rd month then last assessment at the end of 6th month	—

Secondary

Measure	Time frame
Assessment of IgG level before & after treatmentTimepoint: First assessment at the end of 3rd month & then next assessment at the end of 6th month	—

Countries

India

Contacts

Public ContactDr M Murugan

Department of Organon of medicine

drmmuruganhomoeo@gmail.com9443343707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026